ID   3Ao/cDDP
AC   CVCL_C6VJ
SY   3AO/cDDP
DR   Wikidata; Q123030273
RX   CelloPub=CLPUB00731;
RX   PubMed=11372415;
CC   Doubling time: 23.8 +-0.3 hours (CelloPub=CLPUB00731).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6VI ! 3Ao
SX   Female
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
RX   CelloPub=CLPUB00731;
RA   Chen J.-L., Jiang S., Yang R.-F., Liu F.-S., Sun X.-M.;
RT   "Mechanism of drug resistance and reversal with ligustrazine and
RT   cyclosporin A in cisplatin-induced human epithelial ovarian cancer
RT   resistant cell line 3AO/cDDP.";
RL   Chin. J. Cancer Res. 12:197-203(2013).
//
RX   PubMed=11372415;
RA   Chen J.-L., Yang R.-F., Liu F.-S.;
RT   "Establishment of cisplatin-induced multidrug resistant human
RT   epithelial ovarian cancer cell line 3AO/cDDP and its expressions of
RT   multidrug resistance proteins.";
RL   Zhonghua Fu Chan Ke Za Zhi 35:617-620(2000).
//